Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Summit Therapeutics Inc. (SMMT), most recent 12 months reported: net loss $856.09M, free cash flow -$459.82M. Latest balance sheet on file: liquid cash $690.68M. From SEC filings. More on Summit Therapeutics Inc.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: SHUTTLE PHARMACEUTICALS HOLDINGS, INC. · SIONNA THERAPEUTICS, INC. · Skye Bioscience, Inc. · SELLAS Life Sciences Group, Inc. · Semnur Pharmaceuticals, Inc. · SOLIGENIX, INC. · Spruce Biosciences, Inc. · Savara Inc
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.